Literature DB >> 19883972

Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell.

Yan-Hong Zhang1, Qing Wu, Xiu-Ying Xiao, Da-Wei Li, Xing-Peng Wang.   

Abstract

A cisplatin (DDP) resistant cell line (SGC7901/DDP) from a Chinese gastric cancer cell line (SGC7901) was established by step-increasing DDP treatment, and the resultant cell line showed an over 21.9-fold increased resistance to DDP. To identify the mechanism of DDP resistance, the differential gene expression panel was examined by Affymetrix microarray. Among the identified differential genes, 681 genes expression were increased and 1139 genes were decreased. To confirm these gene changes furtherly, one of the upregulated gene, MRP4 was identified with increased mRNA and protein level of SGC7901/DDP by RT-PCR and Western-blot analysis compared with its parental cell line. By using the small interfering RNA (RNAi) to decrease the MRP4 expression, the DDP resistance phenotype of SGC7901/DDP was reversed. These data suggest that MRP4 is a DDP resistance candidate gene of SGC7901 gastric cancer cell line. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19883972     DOI: 10.1016/j.canlet.2009.10.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

Review 1.  Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins.

Authors:  Dustin R Walsh; Thomas D Nolin; Peter A Friedman
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

2.  RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.

Authors:  Yalan Lu; Deqiang Han; Wenjie Liu; Rong Huang; Jinhuan Ou; Xiaoqiao Chen; Xizhe Zhang; Xuezhi Wang; Shijun Li; Lin Wang; Changzheng Liu; Shiying Miao; Linfang Wang; Changwu Ma; Wei Song
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

Review 3.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

4.  Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancer.

Authors:  Yun-Fei Li; Hui-Hua Ji; Zheng-Long Zhang; Tao-Tao Zhang; Wei Gan; Shao-Feng Zhang
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

5.  Effect of Id1 knockdown on formation of osteolytic bone lesions by prostate cancer PC3 cells in vivo.

Authors:  Zhengguo Zhang; Kuanxin Li; Xiaomei Zhang; Zhong Fang; Wei Xiong; Qi Chen; Wenjian Chen; Feng Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

Review 6.  Contribution of tumoral and host solute carriers to clinical drug response.

Authors:  Jason A Sprowl; Torben S Mikkelsen; Hugh Giovinazzo; Alex Sparreboom
Journal:  Drug Resist Updat       Date:  2012-03-28       Impact factor: 18.500

Review 7.  Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.

Authors:  Marwa Matboli; Sarah El-Nakeep; Nourhan Hossam; Alaa Habieb; Ahmed E M Azazy; Ali E Ebrahim; Ziad Nagy; Omar Abdel-Rahman
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 8.  Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.

Authors:  Jessica K Norberg; Earlphia Sells; Hui-Hua Chang; Srinivas R Alla; Shuxing Zhang; Emmanuelle J Meuillet
Journal:  Pharm Pat Anal       Date:  2013-03

Review 9.  Polymorphic transporters and platinum pharmacodynamics.

Authors:  Jason A Sprowl; Rachel A Ness; Alex Sparreboom
Journal:  Drug Metab Pharmacokinet       Date:  2012-09-18       Impact factor: 3.614

10.  Regulation of MRP4 Expression by circHIPK3 via Sponging miR-124-3p/miR-4524-5p in Hepatocellular Carcinoma.

Authors:  Haihong Hu; Yu Wang; Zhiyuan Qin; Wen Sun; Yanhong Chen; Jiaqi Wang; Yingying Wang; Jing Nie; Lu Chen; Sheng Cai; Lushan Yu; Su Zeng
Journal:  Biomedicines       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.